“Future-proofing” Serialization Solutions: The Importance of Strong Level 3 Capabilities
Add bookmark
The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now.
[inlinead]
How can companies manage this transformation with the greatest degree of success while also minimalizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation, and provides business benefits beyond compliance.
Challenges this whitepaper will tackle:
- The importance of Level 3 Applications
- Defining Key Functionalities for a Useful Serialization Level 3 Application
- Download your free copy of the whitepaper below
 | Have Your Say Rate this feature and give us your feedback in the comments section below |
